European Journal of Clinical Pharmacology

, Volume 18, Issue 2, pp 147–150 | Cite as

Nortriptyline therapy in elderly patients: Dosage prediction after single dose pharmacokinetic study

  • Sheila Dawling
  • P. Crome
  • R. A. Braithwaite
  • R. R. Lewis
Originals

Summary

Sixteen depressed elderly patients in hospital (mean age 81 years) received a single oral dose of nortriptyline prior to commencing treatment with this drug. Plasma nortriptyline measurements after the single dose were used to calculate the plasma drug clearance and to predict the daily dose required for each patient to achieve a steady-state concentration within the suggested therapeutic range of 50–150 µg·l−1. Using these dosage regimes, the mean observed steady-state concentration showed a significant correlation with the predicted values (r=0.71, p<0.002). All patients had steady-state concentrations within or very close to this suggested range (mean 106, range 38–157 µg·l−1). Use of the prediction test can prevent the development of toxic plasma concentrations and enhance the possibility of therapeutic success. Our findings suggest that a safe starting dose of nortriptyline for the elderly is 30 mg per day.

Key words

antidepressant geriatric nortriptyline pharmacokinetics prediction 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Åsberg M (1970) Correlation of subjective side effects with plasma concentrations of nortriptyline. Br Med J 4: 18–21Google Scholar
  2. 2.
    Learoyd BM (1972) Psychotropic drugs and the elderly patient. Med J Aust 1: 1131–1133Google Scholar
  3. 3.
    Åsberg M (1974) Plasma nortriptyline levels — relationship to clinical effects. Clin Pharmacol Ther 16: 215–229Google Scholar
  4. 4.
    Burrows GD, Vohra J, Hunt D, Sloman JG, Scoggins BA, Davies B (1976) Cardiac effects of different tricyclic antidepressant drugs. Br J Psychiatry 129: 335–341Google Scholar
  5. 5.
    Dawling S, Braithwaite R (1978) Simplified method for monitoring tricyclic antidepressant therapy using gas-liquid chromatography with nitrogen detection. J. Chromatogr 146: 449–456Google Scholar
  6. 6.
    Åsberg M, Cronholm B, Sjöqvist F, Tuck R (1971) Relationship between plasma level and therapeutic effect of nortriptyline. Br Med J 3: 331–334Google Scholar
  7. 7.
    Kragh-Sørensen P, Eggert-Hansen G, Baastrup PC, Hvidberg EF (1976) Self inhibiting action of nortriptylin's antidepressive effect at high plasma levels. Psychopharmacologia 45: 305–312Google Scholar
  8. 8.
    Ziegler VE, Clayton PJ, Taylor JR, Co BT, Biggs JT (1976) Nortriptyline plasma levels and therapeutic response. Clin Pharmacol Ther 20: 458–463Google Scholar
  9. 9.
    Montgomery S, Braithwaite R, Dawling S, McAuley R (1978) High plasma nortriptyline levels in the treatment of depression. Clin Pharmacol Ther 23: 309–314Google Scholar
  10. 10.
    Åsberg M (1978) Treatment of depression with tricyclic drugs — Pharmacokinetic and pharmacodynamic aspects. Pharmakopsychiatr Neuro-Psychopharmakol 9: 18–26Google Scholar
  11. 11.
    Alexanderson B (1972) Pharmacokinetics of nortriptyline in man after single and multiple oral doses: The predictability of steady-state plasma concentrations from single-dose plasma-level data. Eur J Clin Pharmacol 4: 82–91Google Scholar
  12. 12.
    Alexanderson B (1973) Prediction of steady-state plasma levels of nortriptyline from single oral dose kinetics: A study in twins. Eur J Clin Pharmacol 6: 44–53Google Scholar
  13. 13.
    Braithwaite R, Montgomery S, Dawling S (1978) Nortriptyline in depressed patients with high plasma levels. Clin Pharmacol Ther 23: 303–308Google Scholar
  14. 14.
    Wilkinson GR, Shand DG (1975) A physiological approach to hepatic drug clearance. Clin Pharmacol Ther 18: 377–390Google Scholar
  15. 15.
    Dettli L, Spring P, Ryter S (1971) Multiple dose kinetics and drug dosage in patients with kidney disease. Acta Pharmacol Toxicol 29 (Suppl 3): 211–224Google Scholar
  16. 16.
    Gram LF, Fredericson Overø K (1975) First pass metabolism of nortriptyline in man. Clin Pharmacol Ther 18: 305–314Google Scholar
  17. 17.
    Nies A, Robinson DS, Friedman MJ, Green R, Cooper, TB, Revaris C, Ives JO (1977) Relationship between age and tricyclic antidepressant plasma levels. Am J Psychiatry 134: 790–793Google Scholar
  18. 18.
    Carr AC, Hobson RP (1977) High serum concentrations of antidepressants in elderly patients. Br Med J 2: 1151Google Scholar
  19. 19.
    Johnson DAW (1974) A study of the use of antidepressant medication in general practice. Br J Psychiatry 125: 186–192Google Scholar
  20. 20.
    Tyrer P (1978) Drug treatment of psychiatric patients in general practice. Br Med J 2: 1008–1010Google Scholar

Copyright information

© Springer-Verlag 1980

Authors and Affiliations

  • Sheila Dawling
    • 1
  • P. Crome
    • 2
  • R. A. Braithwaite
    • 1
  • R. R. Lewis
    • 2
  1. 1.Poisons UnitGuy's HospitalLondonEngland
  2. 2.Guy's Department of Geriatric and General MedicineNew Cross HospitalLondonEngland

Personalised recommendations